ITI yields 27.82% · JNJ yields 2.13%● Live data
📍 ITI pulled ahead of the other in Year 1
Combined, ITI + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ITI + JNJ for your $10,000?
Iteris, Inc. provides intelligent transportation systems technology solutions in North America, Europe, South America, and Asia. The company offers smart mobility infrastructure solutions include traveler information systems, transportation performance measurement software, traffic analytics software, transportation operations software, transportation-related data sets, advanced sensing devices, managed services, traffic engineering services, and mobility consulting services. Its products include ClearGuide, ClearRoute, Commercial Vehicle Operations, BlueArgus, TrafficCarma, Vantage Apex, Vantage Fusion, Vantage Next, VantagePegasus, VantageRadius, Vantage Vector, Velocity, SmartCycle, SmartCycle Bike Indicator, SmartSpan, VersiCam, PedTrax, and P-Series products. The company also sells original equipment manufacturer products for the traffic intersection markets, such as traffic signal controllers and traffic signal equipment cabinets. In addition, it offers traffic management centers design, staffing, and operations services; traffic engineering and mobility consulting services include planning, design, development, and implementation of software and hardware-based ITS systems that integrate sensors, video surveillance, computers, and advanced communications equipment; distributes real-time information about traffic conditions; and surface transportation infrastructure systems implementation, and operation and management. Further, the company provides travel demand forecasting and systems engineering, and identify mitigation measures to reduce traffic congestion; ClearMobility platform; and ClearMobility Cloud that enables mobility data management engine, application programming interface framework, and microservices ecosystem. It serves public transportation agencies, municipalities, commercial entities, government agencies, and other transportation infrastructure providers. The company was founded in 1969 and is headquartered in Austin, Texas.
Full ITI Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.